Telesis Bio Inc (TBIO)
Telesis Bio manufactures and sells laboratory equipment, synthetic biology instruments, reagents and associated products and related services to pharmaceutical and academic laboratories. Co.'s solutions include: BioXp 3250 and BioXp 9600 systems, which are an end-to-end automated workstation that enables researchers to go from a DNA sequence to endpoint-ready DNA; BioXp DBC, which is an enzymatic DNA synthesis with design to endpoint-ready synthetic RNA; BioXp portal, which is an online portal that provides guided workflow and design tools for building new DNA sequences; and BioXp De Novo kits, contain the building blocks and reagents for synthetic biology workflow applications.
Company Name: |
Telesis Bio Inc |
Website: |
www.codexdna.com |
Sector: |
Medical Instruments & Supplies |
Number of ETFs Holding TBIO: |
3 |
Total Market Value Held by ETFs: |
$194170 |
Total Market Capitalization: |
$13.00M |
% of Market Cap. Held by ETFs: |
1.49% |
|
|
March 29, 2024 10:59 AM Eastern
Buy (3.33 out of 4)
46th percentile
|
|